Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche to cut 4,800 jobs

By Aaron Smith, staff writer


NEW YORK (CNNMoney.com) -- Swiss health care company Roche said Wednesday it would cut 4,800 jobs over the next two years as part of its "Operation Excellence Program."

Roche said it hoped to save about $2.4 billion through 2012, primarily by cutting or adjusting 6% of its work force of 82,000 people.

In addition to the 4,800 job cuts, the company plans to transfer 800 jobs internally and transfer 700 jobs to "third parties," affecting some 6,300 jobs overall.

Most of the job cuts and transfers would occur in the pharmaceuticals division, primarily in sales, marketing and manufacturing.

In the United States., the company will cut 3,550 jobs. The cuts and other restructuring actions will affect facilities in California, Colorado, New Jersey, South Carolina and Wisconsin. Outside the United States, the reorganization will be focused in Switzerland, Germany and Austria.

The company said it was "adapting cost structures to an increasingly challenging market environment."

Based in Basel, Roche is a drug developer focusing on cancer, virology, inflammation, metabolism and the central nervous system. To top of page

Overnight Avg Rate Latest Change Last Week
30 yr fixed3.85%3.80%
15 yr fixed3.04%3.02%
5/1 ARM3.20%3.14%
30 yr refi3.83%3.78%
15 yr refi3.02%3.03%
Rate data provided
by Bankrate.com
View rates in your area
 
Find personalized rates:
Index Last Change % Change
Dow 21,454.61 143.95 0.68%
Nasdaq 6,234.41 87.79 1.43%
S&P 500 2,440.69 21.31 0.88%
Treasuries 2.22 0.02 1.05%
Data as of 12:09am ET
Company Price Change % Change
Bank of America Corp... 23.88 0.61 2.62%
Advanced Micro Devic... 13.23 -0.17 -1.27%
Ford Motor Co 11.09 0.01 0.09%
General Electric Co 27.08 -0.13 -0.48%
Micron Technology In... 32.24 0.58 1.83%
Data as of Jun 28
Sponsors

Sections

A federal prosecutor called former pharmaceutical CEO Martin Shkreli a fraudster in the opening statements of his criminal fraud trial, but his defense attorney said his client might be strange, but he's not guilty. More

The Federal Reserve on Wednesday will disclose if 34 of the country's banks will be cleared to buy back stock or pay dividends to shareholders. More

It's tough being a first-time buyer in today's housing market. Don't make it even harder (or more expensive) for yourself by making these common mistakes. More